Form 8-K - Current report:
SEC Accession No. 0001437749-25-021978
Filing Date
2025-07-02
Accepted
2025-07-02 16:17:44
Documents
14
Period of Report
2025-07-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20250702_8k.htm   iXBRL 8-K 28056
2 EXHIBIT 99.1 ex_835892.htm EX-99.1 11476
  Complete submission text file 0001437749-25-021978.txt   177670

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20250702.xsd EX-101.SCH 3578
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20250702_def.xml EX-101.DEF 11806
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20250702_lab.xml EX-101.LAB 15857
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20250702_pre.xml EX-101.PRE 12021
16 EXTRACTED XBRL INSTANCE DOCUMENT dyai20250702_8k_htm.xml XML 2957
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251101318
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)